Introduction.

Area of Science:

• Neuroscience
• Gerontology
• Public Health

Background:

• Alzheimer's disease (AD) is the most prevalent form of dementia in individuals over 65, representing 50-60% of cases.
• The global aging population predicts a significant rise in dementia prevalence without effective prevention or treatment.
• AD is a progressive neurodegenerative disorder characterized by cognitive decline, functional impairment, and neuropsychiatric symptoms.

Purpose of the Study:

• To highlight the growing public health challenge posed by Alzheimer's disease.
• To underscore the immense societal and economic burden of AD.
• To emphasize the urgent need for research into the causes and treatments of AD.

Main Methods:

• Literature review on AD prevalence and impact.
• Analysis of demographic trends in aging populations.
• Examination of the economic and social costs associated with AD.

Main Results:

• AD significantly impacts patients, caregivers, and healthcare systems.
• The economic burden includes direct healthcare costs and indirect costs from unpaid care.
• There is a substantial and increasing demand for effective AD interventions.

Conclusions:

• Alzheimer's disease represents a major global health and economic challenge.
• The increasing prevalence necessitates accelerated research for pharmacological treatments.
• Effective prevention and treatment strategies are critical to mitigate the impact of AD.